|
Volumn 50, Issue 2, 2002, Pages 271-276
|
In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPICILLIN;
AZITHROMYCIN;
CLARITHROMYCIN;
CLINDAMYCIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
ERYTHROMYCIN;
GENTAMICIN;
LEVOFLOXACIN;
LINEZOLID;
NEW DRUG;
OXAZOLIDINONE DERIVATIVE;
PENICILLIN G;
POSIZOLID;
STREPTOMYCIN;
TEICOPLANIN;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ANTIINFECTIVE AGENT;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIUM ISOLATE;
CONTROLLED STUDY;
DILUTION;
DRUG POTENCY;
ENTEROCOCCUS FAECIUM;
GRAM POSITIVE BACTERIUM;
IN VITRO STUDY;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
STAPHYLOCOCCUS;
STREPTOCOCCUS;
CLINICAL TRIAL;
DRUG EFFECT;
ENTEROCOCCUS FAECALIS;
GRAM POSITIVE COCCI;
HUMAN;
ISOLATION AND PURIFICATION;
MICROBIOLOGICAL EXAMINATION;
MULTICENTER STUDY;
STATISTICS;
ANTI-BACTERIAL AGENTS;
ENTEROCOCCUS FAECALIS;
ENTEROCOCCUS FAECIUM;
GRAM-POSITIVE COCCI;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
OXAZOLIDINONES;
STREPTOCOCCUS;
|
EID: 0036668114
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/dkf109 Document Type: Article |
Times cited : (19)
|
References (10)
|